Strattera Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea
Conditions: Obstructive Sleep Apnea of Adult Interventions: Drug: Atomoxetine 80mg combined with oxybutynin 5mg; Drug: Venlafaxine 37.5mg; Drug: Atomoxetine 80mg combined with trazodone 100mg; Drug: Placebo Sponsors: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials

Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea
Condition:   OSA Interventions:   Drug: Atomoxetine 80 mg plus Oxybutynin 5 mg;   Drug: Atomoxetine 80 MG;   Drug: Placebo Sponsor:   Brigham and Women's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2023 Category: Research Source Type: clinical trials

Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy
Condition:   Obstructive Sleep Apnea Interventions:   Drug: Atomoxetine;   Drug: Oxybutynin Sponsor:   Brigham and Women's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials